NTLA

Intellia Therapeutics, Inc. Common Stock

$22.56 -$0.25 -1.11%


Own 3 of NTLA at $21.71

Shares Bought9
Shares Sold6
Total15
Shares Owned3
Last Price$22.56
Total Return$8.43
Range Today$22.50 - $23.42
52 Week Range$10.83 - $23.58
Open$22.95
Market Cap$822.63M
Volume/Average82.19K/263.44K
P/E Ratio-
Dividend/Yield-




Intellia Therapeutics, Inc. engages in the development of proprietary, potentially curative therapeutics. It provides scientific expertise, clinical development and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a potential new drug class. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.


Orders

Date Side Shares Price
08-04-2017 17:22:37 buy 1 $16.09
08-04-2017 17:23:33 buy 1 $16.13
08-04-2017 17:24:37 buy 1 $16.14
08-04-2017 17:26:45 buy 1 $16.10
08-04-2017 17:27:48 buy 1 $16.10
08-14-2017 13:19:47 buy 1 $16.93
08-22-2017 15:50:49 sell 1 $17.30
08-23-2017 20:01:24 sell 1 $17.42
08-23-2017 20:08:49 sell 1 $17.26
08-24-2017 16:30:56 sell 1 $17.14
08-24-2017 16:48:14 sell 1 $17.13
08-24-2017 16:56:24 sell 1 $17.11
09-08-2017 15:22:11 buy 1 $21.71
09-08-2017 15:32:06 buy 1 $21.71
09-08-2017 15:34:29 buy 1 $21.70